Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Hoshi

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Modern Rheumatology|August 11, 2012
Analysis of direct medical and nonmedical costs for care of rheumatoid arthritis patients using the large cohort database, IORRAEiichi Tanaka, Daisuke Hoshi, Ataru Igarashi, et al.
Carcinogenesis|June 25, 2019
Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesisTetsuya Matsuura, Yoshiaki Maru, Masashi Izumiya, et al.
Nature Communications|February 3, 2025
Entangling Schrödinger's cat states by bridging discrete- and continuous-variable encodingDaisuke Hoshi, Toshiaki Nagase, Sangil Kwon, et al.
Modern Rheumatology|December 31, 2014
Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort studyEiichi Tanaka, Eisuke Inoue, Daisuke Hoshi, et al.
Rheumatology (Oxford, England)|July 15, 2011
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week studyTsutomu Takeuchi, Yoshiya Tanaka, Koichi Amano, et al.
Modern Rheumatology|November 21, 2013
Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitorsYoshiya Tanaka, Tsutomu Takeuchi, Koichi Amano, et al.
Modern Rheumatology|January 27, 2015
Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012Eri Sato, Eiichi Tanaka, Moeko Ochiai, et al.
Modern Rheumatology|June 9, 2015
Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA databaseDaisuke Hoshi, Eiichi Tanaka, Ataru Igarashi, et al.
Modern Rheumatology|December 24, 2014
Assessment of the effectiveness of golimumab 50-mg and 100-mg regimens in patients with rheumatoid arthritis in daily practiceEri Sato, Eiichi Tanaka, Ayako Nakajima, et al.
Modern Rheumatology|July 30, 2016
Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in JapanEiichi Tanaka, Eisuke Inoue, Rei Yamaguchi, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Modern Rheumatology|August 11, 2012
Analysis of direct medical and nonmedical costs for care of rheumatoid arthritis patients using the large cohort database, IORRAEiichi Tanaka, Daisuke Hoshi, Ataru Igarashi, et al.
Carcinogenesis|June 25, 2019
Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesisTetsuya Matsuura, Yoshiaki Maru, Masashi Izumiya, et al.
Nature Communications|February 3, 2025
Entangling Schrödinger's cat states by bridging discrete- and continuous-variable encodingDaisuke Hoshi, Toshiaki Nagase, Sangil Kwon, et al.
Modern Rheumatology|December 31, 2014
Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort studyEiichi Tanaka, Eisuke Inoue, Daisuke Hoshi, et al.
Rheumatology (Oxford, England)|July 15, 2011
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week studyTsutomu Takeuchi, Yoshiya Tanaka, Koichi Amano, et al.
Modern Rheumatology|November 21, 2013
Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitorsYoshiya Tanaka, Tsutomu Takeuchi, Koichi Amano, et al.
Modern Rheumatology|January 27, 2015
Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012Eri Sato, Eiichi Tanaka, Moeko Ochiai, et al.
Modern Rheumatology|June 9, 2015
Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA databaseDaisuke Hoshi, Eiichi Tanaka, Ataru Igarashi, et al.
Modern Rheumatology|December 24, 2014
Assessment of the effectiveness of golimumab 50-mg and 100-mg regimens in patients with rheumatoid arthritis in daily practiceEri Sato, Eiichi Tanaka, Ayako Nakajima, et al.
Modern Rheumatology|July 30, 2016
Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in JapanEiichi Tanaka, Eisuke Inoue, Rei Yamaguchi, et al.
Pageof 6